The commission opened its investigation of Meta in June 2021, inquiring into the company's collection of Facebook user data, ...
The news outlet is pushing the Commission to release text messages that the E.U.’s top official and Pfizer exchanged as they ...
EADaily, November 18th, 2024. The European Commission forecasts Estonia's economic growth next year at 1.1%. Moreover, by the ...
President of the European Commission, has commented on the suspension of gas supplies to Austria by Russia's energy giant ...
The European Commission has reported on developments related to the food safety control systems of five potential European ...
The European Commission has agreed to allocate €4.1 billion to Ukraine under the Ukraine Facility programme. Source: Prime ...
Economic growth in the eurozone will accelerate in 2025 and 2026, while inflation continues to slow. However, there are risks ...
On November 14, 2024, the EU Listing Act (the “Act”) was published in the Official Journal of the European Union. The Act ...
Following their signature by the presidents of the Council and of the European Parliament, all four legislative acts will be ...
The European Commission (EC) has approved OPUVIZ 40 mg/mL solution for injection in a vial. OPUVIZ is a biosimilar referencing Eylea (aflibercept). The biosimilar has been developed and registered by ...
The European Commission’s decision provides no evidence of competitive harm to rivals or any harm to consumers.
Elahere, which won initial U.S. Food and Drug Administration approval in 2022 for platinum-resistant ovarian cancer and full approval earlier this year, was the key asset in AbbVie's $10.1 billion ...